These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37605233)

  • 21. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone therapy in childhood-onset growth hormone deficiency: adult anthropometric and psychological outcomes.
    Sandberg DE; MacGillivray MH
    Endocrine; 2000 Apr; 12(2):173-82. PubMed ID: 10905377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone retesting during puberty: a cohort study.
    Cavarzere P; Gaudino R; Sandri M; Ramaroli DA; Pietrobelli A; Zaffanello M; Guzzo A; Salvagno GL; Piacentini G; Antoniazzi F
    Eur J Endocrinol; 2020 Jun; 182(6):559-567. PubMed ID: 32337961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sufficiently long-term treatment with combined growth hormone and gonadotropin-releasing hormone analog can improve adult height in short children with isolated growth hormone deficiency (GHD) and in non-GHD short children.
    Tanaka T
    Pediatr Endocrinol Rev; 2007 Sep; 5(1):471-81. PubMed ID: 17925788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The landscape of retesting in childhood-onset idiopathic growth hormone deficiency and its reversibility: a systematic review and meta-analysis.
    Laurer E; Sirovina A; Blaschitz A; Tischlinger K; Montero-Lopez R; Hörtenhuber T; Wimleitner M; Högler W
    Eur J Endocrinol; 2022 Aug; 187(2):265-278. PubMed ID: 35670597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us?
    Plachy L; Amaratunga SA; Dusatkova P; Maratova K; Neuman V; Petruzelkova L; Zemkova D; Obermannova B; Snajderova M; Kolouskova S; Sumnik Z; Lebl J; Pruhova S
    Front Endocrinol (Lausanne); 2022; 13():1102968. PubMed ID: 36714562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
    Albertsson Wikland K; Alm F; Aronsson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson S; Kriström B; Marcus C; Moëll C; Nilsson KO; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Acta Paediatr Suppl; 1999 Feb; 88(428):80-4. PubMed ID: 10102059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone therapy for 3 years: the OZGROW experience.
    Cowell CT; Dietsch S; Greenacre P
    J Paediatr Child Health; 1996 Apr; 32(2):86-93. PubMed ID: 8860379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
    Weinzimer SA; Homan SA; Ferry RJ; Moshang T
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Growth Hormone on Final Height in Children with Idiopathic Short Stature: A UAE, Eastern Region Experience.
    Mreish S; Kaplan W; Chedid F
    Oman Med J; 2017 Nov; 32(6):467-470. PubMed ID: 29218122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 40. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.